Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain
    • - Hospital at Home
    • - Workplace of the Future
    • - Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • Data Center
    • Data Center Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • MORE +
    • Contact Us
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Law & Regulation
June 07, 2022 02:21 PM

FTC takes aim at PBM business practices in new inquiry

Maya Goldman
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    drugs-money_i.png
    MH Illustration

    The Federal Trade Commission will intensify its scrutiny of pharmacy benefit manager business practices, the agency announced Tuesday.

    The probe, which the commission unanimously approved, will focus on how vertical integration in the PBM sector affects access and pricing in the prescription drug market, according to a news release.

    The FTC will require the six largest PBMs to provide information about their activities. The regulator plans to send compulsory orders to CVS Health's CVS Caremark, Cigna's Express Scripts, UnitedHealth Group's OptumRx, Humana, Blue Cross and Blue Shield-affiliated Prime Therapeutics, and MedImpact Healthcare Systems. CVS Caremark, Express Scripts and OptumRx collectively control about 80% of the PBM market.

    "The FTC's forthcoming PBM inquiry will examine several of the most common complaints about PBMs and will seek to assist policymakers in determining whether Americans would benefit from reforms to this critical industry," commission Chair Lina Khan said in a news release.

    The agency will look into matters such as the clawbacks PBMs charge to unaffiliated pharmacies, efforts to direct patients toward PBM-owned pharmacies, prior authorization policies, and the effects of manufacturer rebates and fees on formulary design.

    The FTC issued a public request for information about how PBMs affect the healthcare system in February, following a failed vote to initiate a review of the industry. In response, provider groups urged the regulator to investigate the companies, alleging their practices harm quality and threaten providers' finances.

    The National Community Pharmacists Association applauds the FTC's action and hopes it leads to meaningful reforms, CEO Douglas Hoey said in a news release.

    "PBMs behave like monopolies. Their secretive, anticompetitive practices increase prescription drug prices, limit consumer choice and stymie competition. They've escaped serious scrutiny for far too long, but this study will bring their dirty laundry out into the open," Hoey said.

    The Pharmaceutical Care Management Association, a PBM trade group, believes the FTC probe will confirm that its members reduce patient costs, President and CEO JC Scott said in a statement.

    "PBMs are holding drug companies accountable by negotiating the lowest possible cost on behalf of consumers," Scott said. "Drug manufacturer price-setting is the root cause of high drug costs. The most effective study of issues around drug costs for consumers would examine the entire supply chain."

    CVS Caremark looks forward to working cooperatively with the FTC, a spokesperson wrote in an email. Prime Therapeutics also intends to cooperate, General Counsel Mike Kolar said in statement. Humana likewise pledged to cooperate, a spokesperson wrote in an email. OptumRx referred questions to PCMA. Express Scripts and MedImpact Healthcare Systems didn't respond to requests for comment.
    These companies may keep their information close to the chest, said Lucas Morgan, of the law firm Frier Levitt. "Most likely, each one of these PBMs is going to interpret these compulsory orders in the most narrow scope or fashion possible," he said. "There's going to be a big fight ahead between the FTC and the six very powerful PBMs."
    The evidence regarding PBMs' effects on patients and providers is uncertain. University of Southern California researchers have linked the larger rebates that PBMs often demand to rising drug prices. But Centers for Medicare and Medicaid Services actuaries have reported contrary data that indicates rebates constrain drug spending growth.

    The FTC reached consensus on the PBM inquiry following a deadlock in February in part because Alvaro Bedoya, nominated by President Joe Biden, joined the panel last month. Bedoya advocated for a more aggressive investigation, and noted that Delaware and Ohio audits uncovered evidence of deceptive conduct, in a news release Tuesday.

    Commissioners Noah Joshua Phillips and Christine Wilson, whom President Donald Trump nominated to the panel, dissented in February but joined the others in supporting the study announced Tuesday.

    The previous plan was "hastily prepared" and modified shortly before the vote four months ago, the two commissioners said in a joint news release Tuesday.

    "We are hopeful that this study will generate useful information about prescription drug costs and the role and impact of PBMs. We also hope that agency leadership will commit to devoting the necessary resources to the project moving forward," Phillips and Wilson said.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Copy of lab_i.jpg
    FDA eases restrictions on blood donations from gay men
    US-legal-healthcare_i.png
    FTC proposes ban on employee noncompete clauses
    Most Popular
    1
    More healthcare organizations at risk of credit default, Moody's says
    2
    Centene fills out senior executive team with new president, COO
    3
    SCAN, CareOregon plan to merge into the HealthRight Group
    4
    Blue Cross Blue Shield of Michigan unveils big push that lets physicians take on risk, reap rewards
    5
    Bright Health weighs reverse stock split as delisting looms
    Sponsored Content
    Daily Dose Newsletter: Sign up to receive a late afternoon weekday roundup of that day’s breaking news and developments in healthcare.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain
        • - Hospital at Home
        • - Workplace of the Future
        • - Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • Data Center
      • Data Center Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • MORE +
      • Contact Us
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing